For comparison, and as a control to assess the specificity of BDNF among other known neuronal activity-regulated paracrine factors1–3, soluble NLGN3 was similarly tested and exerted no acute effect on glutamatergic current amplitude in glioma cells (Extended Data Fig. 6e,f). This evidence concerns the gene NLGN3 and central nervous system cancer.